top of page

Policy Advocacy

Our pediatric diabetes quality improvement program has the ultimate goal of improving health outcomes and quality of life for our patients and families. We also recognize our patients and families have concerns regarding legal policies that affect diabetes management. Here you can find helpful links and petitions relating to your child's diabetes care.

Wayne County Safe at School® Proposal

 

Help support the American Diabetes Association’s (ADA) FY24 Congressionally Directed Spending request to provide Safe at School® training in Wayne County schools.

 

The ADA’s Safe at School (SAS) program provides training and support to school nurses and school personnel in order that they may assist students with diabetes with their diabetes care while at school. This training is necessary to schools’ ability to ensure our students with diabetes are medically safe at school and have the same educational opportunities as their peers.

 

This is a sample letter of support. Please review and, if you would like to support the request, you may either customize this letter to reflect your own experiences or write your own letter. It does not have to be lengthy, just sharing your support for the request. Please send your letter to Gary Dougherty, ADA Director of State Government Affairs, by Tuesday, March 21, 2023 at GDougherty@diabetes.org.

Michigan Medicaid Continuous Glucose Monitor Policy Proposal

 

For people living with diabetes, continuous glucose monitors (CGMs) provide significant benefits for diabetes management and help patients avoid or delay serious complications and hospitalizations. This new policy proposal would expand CGM coverage for Michigan Medicaid and Children's Special Health Care Services (CSHCS) recipients.

 

Currently, Michigan Medicaid does not typically cover continuous glucose monitors (CGMs) for those living with other types of diabetes besides Type 1 Diabetes (such as Type 2 Diabetes, Medication-Induced, etc.). The proposed policy change would include anyone living with any type insulin-dependent diabetes. It would also eliminate the prior authorization process for individuals with T1D, decreasing wait times (although a prior authorization would be required for individuals with other types of insulin-depended diabetes).

 

The proposed policy can be viewed at the Michigan Department of Health and Human Services’ website. The American Diabetes Association has also created this document to help see the proposed changes more clearly.

Please take a moment to review the policy proposal and be sure to share any feedback or comments to Ms. Lisa Trumbell at TrumbellL@michigan.gov by Thursday, March 30, 2023 when the 35-day comment period will expire. It is suggested you use Comments re: 2302-DMEPOS as your subject line.

Please consider that the proposed policy still requires physician documentation within 90 days, requires a prior authorization for individuals with other types of diabetes (non-T1D), and does not state that CGMs be expanded to include pharmacy benefits, in addition to the current durable medical equipment (DME) benefit. If you would like these things changed as well, or have other feedback on the proposed policy, include these in your comments.

bottom of page